These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2083028)

  • 1. Design, synthesis and bronchodilatory activity of a series of quinazoline-3-oxides.
    Combs DW; Rampulla MS; Russell RK; Rampulla RA; Klaubert DH; Ritchie D; Meeks AS; Kirchner T
    Drug Des Deliv; 1990 Oct; 6(4):241-54. PubMed ID: 2083028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and bronchodilator activity of new quinazolin derivative.
    Zabeer A; Bhagat A; Gupta OP; Singh GD; Youssouf MS; Dhar KL; Suri OP; Suri KA; Satti NK; Gupta BD; Qazi GN
    Eur J Med Chem; 2006 Mar; 41(3):429-34. PubMed ID: 16430993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bronchodilation and structure-activity relationship studies on new 6-substituted benzimidazo[1,2-c]quinazolines.
    Bahekar RH; Rao AR
    Arzneimittelforschung; 2000 Aug; 50(8):712-6. PubMed ID: 10994154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of some new theophylline derivatives with bronchodilator and antibacterial activities.
    Hayallah AM; Elgaher WA; Salem OI; Alim AA
    Arch Pharm Res; 2011 Jan; 34(1):3-21. PubMed ID: 21468910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and bronchodilatory activity of four new derivatives of deoxyvasicine.
    Ojo B; Findsen LA; Igarashi N; Kong B; Chowdhury BK
    Drug Des Discov; 1996 Mar; 14(1):1-14. PubMed ID: 8854041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of some 10-substituted 2,3-dihydroimidazo[2,1-b]quinazolin-5(10H)-ones, a new class of bronchodilators.
    Hardtmann GE; Koletar G; Pfister OR; Gogerty JH; Iorio LC
    J Med Chem; 1975 May; 18(5):447-53. PubMed ID: 239232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of new 8-anilide theophylline derivatives as bronchodilators and antibacterial agents.
    Hayallah AK; Talhouni AA; Alim AA
    Arch Pharm Res; 2012 Aug; 35(8):1355-68. PubMed ID: 22941478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel bronchodilatory quinazolines and quinoxalines: synthesis and biological evaluation.
    Špulák M; Pourová J; Vopršálová M; Mikušek J; Kuneš J; Vacek J; Ghavre M; Gathergood N; Pour M
    Eur J Med Chem; 2014 Mar; 74():65-72. PubMed ID: 24445313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
    Howell RE; Sickels BD; Woeppel SL
    J Pharmacol Exp Ther; 1993 Feb; 264(2):609-15. PubMed ID: 8437112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New bronchodilators. II. 3H-imidazo[4,5-c]quinolin-4(5H)-ones.
    Suzuki F; Kuroda T; Hayashi H; Nakasato Y; Manabe H; Ohmori K; Kitamura S
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3245-52. PubMed ID: 1294327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, evaluation and structure-activity relationships of 5-alkyl-2,3-dihydroimidazo[1,2-c] quinazoline, 2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-thiones and their oxo-analogues as new potential bronchodilators.
    Bahekar RH; Rao AR
    Arzneimittelforschung; 2001; 51(4):284-92. PubMed ID: 11367868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and bronchodilatory activity of some nitrogen bridgehead compounds.
    Jindal DP; Bhatti RS; Ahlawat S; Gupta R
    Eur J Med Chem; 2002 May; 37(5):419-25. PubMed ID: 12008056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 4-butyl-1-substituted-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as new class of H(1)-antihistaminic agents.
    Alagarsamy V; Shankar D; Murugesan S
    Biomed Pharmacother; 2008 Mar; 62(3):173-8. PubMed ID: 17936567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchodilator substances. Part 1: synthesis and structure-activity relationships between new benzoic and heterocyclic amide derivatives.
    Regnier GL; Canevari RJ; Duhault JL; Laubie ML
    Arzneimittelforschung; 1974 Dec; 24(12):1969-70. PubMed ID: 4480358
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and pharmacological investigation of novel 1-substituted-4-phenyl-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-ones as a new class of H1-antihistaminic agents.
    Alagarsamy V; Giridhar R; Yadav MR
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1877-80. PubMed ID: 15780625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the lipoxygenase inhibitor N-hydroxy-N-(6-methoxy-3,4-dihydro-2-naphthylmethyl)urea on bronchoconstriction and lung vascular permeability in anaphylactic guinea pigs.
    Geist C; Schneider J; Zimmer O
    Arzneimittelforschung; 1995 Feb; 45(2):155-8. PubMed ID: 7710438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilating effects of bambuterol on bronchoconstriction in guinea pigs.
    Xie QM; Zeng LH; Zheng YX; Lu YB; Yang QH
    Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):651-4. PubMed ID: 10678133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological investigation of novel 1-substituted-4-(4-substituted phenyl)-4H-[1,2,4]triazolo[4,3-a]quinazolin-5-ones as a new class of H1-antihistamine agents.
    Alagarsamy V; Giridhar R; Yadav MR
    J Pharm Pharmacol; 2006 Sep; 58(9):1249-55. PubMed ID: 16945184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
    Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
    J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine kinase inhibitors. 9. Synthesis and evaluation of fused tricyclic quinazoline analogues as ATP site inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor.
    Rewcastle GW; Palmer BD; Bridges AJ; Showalter HD; Sun L; Nelson J; McMichael A; Kraker AJ; Fry DW; Denny WA
    J Med Chem; 1996 Feb; 39(4):918-28. PubMed ID: 8632415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.